Articoli con mandati relativi all'accesso pubblico - Serge KorjianUlteriori informazioni
Non disponibili pubblicamente: 2
The CSL112-2001 trial: safety and tolerability of multiple doses of CSL112 (apolipoprotein AI [human]), an intravenous formulation of plasma-derived apolipoprotein AI, among …
CM Gibson, M Kerneis, MK Yee, Y Daaboul, S Korjian, AP Mehr, P Tricoci, ...
American heart journal 208, 81-90, 2019
Mandati: US National Institutes of Health
Prevention of venous thromboembolism in hospitalized medically ill patients: a US perspective
AC Spyropoulos, W Ageno, AT Cohen, CM Gibson, SZ Goldhaber, ...
Thrombosis and Haemostasis 120 (06), 924-936, 2020
Mandati: US National Institutes of Health
Disponibili pubblicamente: 8
Extended-duration betrixaban reduces the risk of stroke versus standard-dose enoxaparin among hospitalized medically ill patients: an APEX trial substudy (acute medically ill …
CM Gibson, G Chi, R Halaby, S Korjian, Y Daaboul, P Jain, D Arbetter, ...
Circulation 135 (7), 648-655, 2017
Mandati: US National Institutes of Health, Patient-Centered Outcomes Research Institute
Comparison of fatal or irreversible events with extended‐duration betrixaban versus standard dose enoxaparin in acutely ill medical patients: an APEX trial substudy
CM Gibson, S Korjian, G Chi, Y Daaboul, P Jain, D Arbetter, ...
Journal of the American Heart Association 6 (7), e006015, 2017
Mandati: American Heart Association
ApoA-I infusion therapies following acute coronary syndrome: Past, present, and future
A Kalayci, CM Gibson, PM Ridker, SD Wright, BA Kingwell, S Korjian, ...
Current atherosclerosis reports 24 (7), 585-597, 2022
Mandati: US National Institutes of Health, American Heart Association
Pre-hospital antiplatelet therapy for STEMI patients undergoing primary percutaneous coronary intervention: what we know and what lies ahead
E Fabris, S Korjian, BS Coller, JM Ten Berg, CB Granger, CM Gibson, ...
Thrombosis and haemostasis 121 (12), 1562-1573, 2021
Mandati: US National Institutes of Health
Safety and efficacy of rivaroxaban when added to aspirin monotherapy among stabilized post‐acute coronary syndrome patients: a pooled analysis study of ATLAS ACS‐TIMI 46 and …
WJ Gibson, CM Gibson, MK Yee, S Korjian, Y Daaboul, AN Plotnikov, ...
Journal of the American Heart Association 8 (5), e009451, 2019
Mandati: American Heart Association
Early and late recurrent cardiovascular events among high‐risk patients with an acute coronary syndrome: meta‐analysis of phase III studies and implications on trial design
G Chi, JJ Lee, SHA Kazmi, C Fitzgerald, S Memar Montazerin, A Kalayci, ...
Clinical Cardiology 45 (3), 299-307, 2022
Mandati: US National Institutes of Health, American Heart Association
Patient adherence to secondary prevention therapies after an acute coronary syndrome: a scoping review
MC Bahit, S Korjian, Y Daaboul, S Baron, DL Bhatt, A Kalayci, G Chi, ...
Clinical Therapeutics, 2023
Mandati: US National Institutes of Health
Drug-coated balloons in the real world: do they hold up?
EA Secemsky, S Korjian
EuroIntervention 18 (11), e870, 2022
Mandati: US National Institutes of Health
Le informazioni sulla pubblicazione e sul finanziamento vengono stabilite automaticamente da un software